IL144852A0 - Use of fluorinated triazoles for treating pain and affective or attention disorders - Google Patents
Use of fluorinated triazoles for treating pain and affective or attention disordersInfo
- Publication number
- IL144852A0 IL144852A0 IL14485200A IL14485200A IL144852A0 IL 144852 A0 IL144852 A0 IL 144852A0 IL 14485200 A IL14485200 A IL 14485200A IL 14485200 A IL14485200 A IL 14485200A IL 144852 A0 IL144852 A0 IL 144852A0
- Authority
- IL
- Israel
- Prior art keywords
- affective
- treating pain
- attention disorders
- triazoles
- fluorinated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/259,911 US6054471A (en) | 1999-03-01 | 1999-03-01 | Use of fluorinated triazoles in treating neuropathic pain |
US09/259,910 US6156775A (en) | 1999-03-01 | 1999-03-01 | Use of fluorinated triazoles in treating affective and attention disorders |
PCT/EP2000/001626 WO2000051577A2 (en) | 1999-03-01 | 2000-02-28 | Use of fluorinated triazoles for treating pain and affective or attention disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144852A0 true IL144852A0 (en) | 2002-06-30 |
Family
ID=26947613
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14485200A IL144852A0 (en) | 1999-03-01 | 2000-02-28 | Use of fluorinated triazoles for treating pain and affective or attention disorders |
IL144852A IL144852A (en) | 1999-03-01 | 2001-08-09 | Use of fluorinated triazoles for the preparation of drugs for the treatment of nervous system pain |
IL189190A IL189190A0 (en) | 1999-03-01 | 2008-02-03 | Use of fluorinated triazoles for treating pain and affective or attention disorders |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL144852A IL144852A (en) | 1999-03-01 | 2001-08-09 | Use of fluorinated triazoles for the preparation of drugs for the treatment of nervous system pain |
IL189190A IL189190A0 (en) | 1999-03-01 | 2008-02-03 | Use of fluorinated triazoles for treating pain and affective or attention disorders |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP1156856B1 (pt) |
JP (1) | JP4700195B2 (pt) |
KR (2) | KR100839765B1 (pt) |
CN (2) | CN1195516C (pt) |
AT (1) | ATE303179T1 (pt) |
AU (1) | AU764508B2 (pt) |
BR (1) | BR0008606A (pt) |
CA (1) | CA2362411C (pt) |
CY (1) | CY1115241T1 (pt) |
DE (1) | DE60022317T2 (pt) |
DK (2) | DK1609505T3 (pt) |
ES (2) | ES2441208T3 (pt) |
HK (1) | HK1086775A1 (pt) |
HU (2) | HU230044B1 (pt) |
ID (1) | ID29891A (pt) |
IL (3) | IL144852A0 (pt) |
NO (2) | NO328927B1 (pt) |
NZ (1) | NZ513716A (pt) |
PL (2) | PL197158B1 (pt) |
PT (1) | PT1609505E (pt) |
RU (1) | RU2238725C2 (pt) |
SI (1) | SI1609505T1 (pt) |
SK (2) | SK286203B6 (pt) |
TW (1) | TW513301B (pt) |
WO (1) | WO2000051577A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9718789B2 (en) | 2015-01-30 | 2017-08-01 | Neurocrine Biosciences, Inc. | Substituted triazoles and methods relating thereto |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1511195A (en) * | 1976-10-18 | 1978-05-17 | Ici America Inc | Triazole derivatives |
FI93544C (fi) * | 1985-04-18 | 1995-04-25 | Ciba Geigy Ag | Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi |
-
2000
- 2000-02-22 TW TW089103041A patent/TW513301B/zh not_active IP Right Cessation
- 2000-02-28 ES ES05018762.4T patent/ES2441208T3/es not_active Expired - Lifetime
- 2000-02-28 PL PL350418A patent/PL197158B1/pl unknown
- 2000-02-28 EP EP00912515A patent/EP1156856B1/en not_active Expired - Lifetime
- 2000-02-28 IL IL14485200A patent/IL144852A0/xx active IP Right Grant
- 2000-02-28 WO PCT/EP2000/001626 patent/WO2000051577A2/en active Application Filing
- 2000-02-28 RU RU2001126350A patent/RU2238725C2/ru active
- 2000-02-28 HU HU1000576A patent/HU230044B1/hu active IP Right Revival
- 2000-02-28 DK DK05018762.4T patent/DK1609505T3/en active
- 2000-02-28 SK SK1225-2001A patent/SK286203B6/sk not_active IP Right Cessation
- 2000-02-28 DK DK00912515T patent/DK1156856T3/da active
- 2000-02-28 SI SI200031078T patent/SI1609505T1/sl unknown
- 2000-02-28 BR BR0008606-1A patent/BR0008606A/pt not_active Application Discontinuation
- 2000-02-28 JP JP2000602045A patent/JP4700195B2/ja not_active Expired - Lifetime
- 2000-02-28 DE DE60022317T patent/DE60022317T2/de not_active Expired - Lifetime
- 2000-02-28 NZ NZ513716A patent/NZ513716A/en not_active IP Right Cessation
- 2000-02-28 CN CNB008044929A patent/CN1195516C/zh not_active Expired - Lifetime
- 2000-02-28 ES ES00912515T patent/ES2244413T3/es not_active Expired - Lifetime
- 2000-02-28 CN CNA2004100120495A patent/CN1636562A/zh active Pending
- 2000-02-28 KR KR1020017011098A patent/KR100839765B1/ko active IP Right Grant
- 2000-02-28 PT PT50187624T patent/PT1609505E/pt unknown
- 2000-02-28 SK SK5002-2008A patent/SK286775B6/sk not_active IP Right Cessation
- 2000-02-28 CA CA002362411A patent/CA2362411C/en not_active Expired - Lifetime
- 2000-02-28 EP EP05018762.4A patent/EP1609505B1/en not_active Expired - Lifetime
- 2000-02-28 KR KR1020077029858A patent/KR100839766B1/ko active IP Right Grant
- 2000-02-28 HU HU0302780A patent/HU227602B1/hu unknown
- 2000-02-28 AT AT00912515T patent/ATE303179T1/de active
- 2000-02-28 PL PL382172A patent/PL199660B1/pl unknown
- 2000-02-28 AU AU34253/00A patent/AU764508B2/en not_active Expired
- 2000-02-28 ID IDW00200101864A patent/ID29891A/id unknown
-
2001
- 2001-08-09 IL IL144852A patent/IL144852A/en not_active IP Right Cessation
- 2001-08-28 NO NO20014180A patent/NO328927B1/no not_active IP Right Cessation
-
2006
- 2006-06-13 HK HK06106764.5A patent/HK1086775A1/xx not_active IP Right Cessation
-
2008
- 2008-02-03 IL IL189190A patent/IL189190A0/en unknown
-
2009
- 2009-08-31 NO NO20092921A patent/NO334104B1/no not_active IP Right Cessation
-
2014
- 2014-02-26 CY CY20141100151T patent/CY1115241T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1487877A4 (en) | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS | |
ZA200309808B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL139591A0 (en) | Combination therapy for treatment of bipolar disorders | |
EP0892632A4 (en) | AGENTS FOR USE IN PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDERS | |
HK1068350A1 (en) | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain | |
PL345364A1 (en) | The use of valproic acid analog for the treatment and prevention of migraine and affective illness | |
HK1040908A1 (en) | Use of optically pure (R)-tofisopam for treating and preventing anxiety disorders. | |
IL189190A0 (en) | Use of fluorinated triazoles for treating pain and affective or attention disorders | |
HK1047549A1 (en) | Il6ril6 chimera for the treatment of neurodegeneraive diseases. | |
AU2001233955A1 (en) | Diagnosis and treatment of bipolar affective disorder | |
BG103543A (en) | The use of pramipexol in the treatment of the uneasy legs syndrome | |
MXPA04010816A (es) | Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares. | |
ZA9711468B (en) | New use of comt inhibitors | |
ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen | |
ATE369143T1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
ZA200107138B (en) | Use of fluorinated triazoles for treating pain and affective or attention disorders. | |
ATE216884T1 (de) | Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden | |
BR0206918A (pt) | Uso de iloperidona | |
UA29506C2 (uk) | Лікувально-косметичний засіб "фіто-пелоїд" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |